Search results for "Virus Disease"

showing 10 items of 1907 documents

Rationale and evidence on the use of tocilizumab in COVID-19: A systematic review. Authors’ reply

2021

lcsh:RC705-779Pulmonary and Respiratory Medicine2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINECOVID-19lcsh:Diseases of the respiratory systemAntibodies Monoclonal HumanizedSeverity of Illness Indexchemistry.chemical_compoundTocilizumabchemistrySeverity of illnessHumansMedicinebusinessIntensive care medicineLetter to the Editor
researchProduct

Further spread of West Nile virus in Italy.

2010

Following two consecutive years of West Nile virus (WNV) circulation in Italy, new foci of infection were observed in August 2010 in Sicily and Molise in southern and central Italy, respectively. These incidents were far from the previous infected area in northern Italy, thereby confirming the ability of WNV to spread to new areas and affect new host populations. © Istituto G. Caporale 2010.

lcsh:Veterinary medicinevirusesViruvirus diseasesWest Nilenervous system diseasesVirusZoonosisItalylcsh:SF600-1100Animalslcsh:Animal cultureZoonosis.Italy; Virus; West Nile; ZoonosisWest Nile Feverlcsh:SF1-1100
researchProduct

Adoption of digital innovations in rural enterprises during COVID-19

2021

The COVID-19 pandemic has rapidly affected the operating conditions of enterprises. Traditional customers and operational models are changing radically in the short term. Digitalisation and digital methods provide an opportunity to re-organise working methods and create a new kind of business to replace old methods and business models. Compared to urban enterprises, rural enterprises have less experience with digital tools and are less likely to adopt digital innovations. This makes rural enterprises especially vulnerable. The purpose of this study is to provide insights into how micro-enterprises and small and medium-sized enterprises in rural areas have addressed the COVID-19 pandemic, th…

liiketoimintamallitmikroyrityksetCoronavirus disease 2019 (COVID-19)COVID-19kehittäminenyrityksetinnovaatiotpienyrityksetyritystoimintaliiketoimintamaaseutuyrityksetmaaseutuBusinessdigitalisaatiopienet ja keskisuuret yrityksetIndustrial organization
researchProduct

Prejudice and acculturation preferences towards Russian immigrants in Finland

2019

Russian minorities are one of the most significant minority groups in Finland. Research on Finnish-Russian relations, suggests that Finnish adolescents have feelings of prejudice towards Russian im...

media_common.quotation_subject05 social sciencesImmigrationvirus diseases050801 communication & media studies050109 social psychologyAcculturation0508 media and communicationsFeeling0501 psychology and cognitive sciencesPsychologySocial psychologygeographic locationsPrejudice (legal term)media_commonMigration and Development
researchProduct

Stay at Home and Teach: A Comparative Study of Psychosocial Risks Between Spain and Mexico During the Pandemic

2020

Context The emergency situation caused by coronavirus disease 2019 (COVID-19) has affected different facets of society. Although much of the attention is focused on the health sector, other sectors such as education have also experienced profound transformations and impacts. This sector is usually highly affected by psychosocial risks, and this could be aggravated during the current health emergency. Psychosocial risks may cause health problems, lack of motivation, and a decrease of effectiveness at work, which in turn affect the quality of teaching. Despite their importance, there are hardly any studies that analyze psychosocial risks of non-university teachers during a health emergency su…

media_common.quotation_subjecteducationlcsh:BF1-990Context (language use)BurnoutAffect (psychology)050105 experimental psychology03 medical and health sciencesSocial support0302 clinical medicineEnvironmental healthPerceptionPandemicPsychology0501 psychology and cognitive sciencesMexicoGeneral PsychologyOriginal Researchmedia_commonteachers05 social sciencespsychosocial riskslcsh:PsychologyWork (electrical)pandemic (COVID-19)Spaincoronavirus disease 2019 (COVID-19)PsychologyPsychosocial030217 neurology & neurosurgeryFrontiers in Psychology
researchProduct

Norovirus infections and seroprevalence of genotype gii.4-specific antibodies in a spanish population

2015

Genotype II.4 noroviruses (NoVs) are a leading cause of epidemic acute gastroenteritis in children and adults worldwide. The prevalence of different NoV genotypes causing outbreaks and sporadic cases of acute gastroenteritis in the region of Valencia, Spain, during a 4-year period (2008–11) was investigated. NoVs were detected in 42 out of 55 (76.3%) outbreaks and in 26 out of 332 (7.8%) sporadic cases of acute gastroenteritis. Genogroup GII strains were predominant in outbreaks and sporadic cases. Different genotype GII.4 variants were found (Yerseke_2006a, Den Haag_2006b, Apeldoorn_2007, and New Orleans_2009), with the latter variant detected most frequently (35.3%). A recombinant P domai…

medicine.diagnostic_testvirusesvirus diseasesOutbreakBiologymedicine.disease_causeVirologyMicrobiologyTiterfluids and secretionsInfectious DiseasesAntigenVirologyImmunoassayGenotypemedicineNorovirusbiology.proteinSeroprevalenceAntibodyJournal of Medical Virology
researchProduct

Screening for inhibitors of HIV gp120-CD4 binding using an enzyme-linked immunoabsorbent assay.

1993

Binding of the HIV-1 major viral surface glycoprotein, gp120, to the major cell receptor, CD4, is essential for HIV infection of the target cell and syncytium formation. An enzyme-linked immunoassay using solid phase CD4 was used to quantitate the binding of HIV-1 gp120 to CD4, and to assess the activity and mechanism of action of putative inhibitors of that reaction. Monoclonal antibodies to the gp120 binding site on CD4 (e.g., Leu3a) blocked gp120 binding, while monoclonal antibodies to other portions of CD4 (e.g. OKT4) did not. Both aurintricarboxylic acid and sulfonated polysaccharides (e.g., dextran sulfate) blocked CD4-gp120 interactions by binding to the CD4 component. Human polyclon…

medicine.drug_classvirusesEnzyme-Linked Immunosorbent AssayHIV Envelope Protein gp120Monoclonal antibodyAntiviral Agentschemistry.chemical_compoundPolysaccharidesVirologyLectinsAurintricarboxylic acidmedicineGlycoproteinschemistry.chemical_classificationbiologyLigand binding assayvirus diseasesLectinReproducibility of ResultsMolecular biologyRecombinant ProteinsEnzymechemistryMechanism of actionPolyclonal antibodiesCD4 Antigensbiology.proteinHIV-1medicine.symptomAntibodyJournal of virological methods
researchProduct

Conformational and linear epitopes on virus-like particles of human papillomavirus type 33 identified by monoclonal antibodies to the minor capsid pr…

1995

The organization of epitopes on the minor capsid protein L2 of human papillomavirus (HPV) type 33 has been analysed using three monoclonal antibodies (MAbs) generated against a large fragment of the L2 protein (amino acids 82-259) expressed as a glutathione S-transferase fusion protein. The topology of the L2 epitopes has been investigated with respect to the structure of HPV-33 virus-like particles (VLPs). Two of the MAbs reacted with linear epitopes which were mapped to amino acids 153-160 and 163-170, respectively. These epitopes were accessible in denatured but not in native VLPs consisting of L1 and L2, suggesting an internal location. The third antibody was unable to detect denatured …

medicine.drug_classvirusesMolecular Sequence DataBiologyMonoclonal antibodyEpitopeEpitopesMiceCapsidAntigenAntibody SpecificityVirologymedicineAnimalsHumansAmino Acid SequenceAntigens ViralPapillomaviridaechemistry.chemical_classificationMice Inbred BALB CAntibodies Monoclonalvirus diseasesOncogene Proteins ViralUterine Cervical DysplasiaFusion proteinVirologyMolecular biologyAmino acidCapsidchemistryDNA Viralbiology.proteinCapsid ProteinsAntibodyEpitope MappingConformational epitopeJournal of General Virology
researchProduct

Severe asthma at COVID-19 time: what is new on biologic therapies.

2021

medicine.medical_specialty2019-20 coronavirus outbreakAsthma therapyCoronavirus disease 2019 (COVID-19)business.industrySevere asthmaBiologic therapiesMEDLINECOVID-19General MedicineSettore MED/10 - Malattie Dell'Apparato Respiratoriomedicine.diseaseSeverity of Illness IndexAsthmaAsthma; COVID-19; Humans; Severity of Illness Index; Biological TherapyBiological TherapyInternal medicineSeverity of illnessmedicineHumansbusinessAsthmaHumanMinerva medica
researchProduct

COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Ita…

2021

The coronavirus disease 2019 (COVID-19) pandemic has not finished yet, and the most promising option towards its ending is widespread vaccination. Because patients with inflammatory bowel diseases (IBDs), namely Crohn’s disease (CD) and ulcerative colitis (UC), often require immune-modifying treatment, which might increase the risk of opportunistic infection,1 their vaccination history for several infectious diseases is routinely checked, and when inadequate, vaccination is performed at diagnosis or ideally before immune suppressive treatment is started.1 However, IBD patients were not found to be at an increased risk of developing COVID-19 or of experiencing a more severe disease course.2

medicine.medical_specialty2019-20 coronavirus outbreakCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)IBDBrief Report - ClinicalInternal medicinemedicineHumansImmunology and AllergyIn patientAcademicSubjects/MED00260SARS-CoV-2business.industryVaccinationGastroenterologyCOVID-19Inflammatory Bowel DiseasesInflammatory Bowel DiseasesCOVID-19 Vaccines HumanVaccinationIBD Crohn Ulcerative Colitis Vaccination Covid 19 Sars-Cov 2COVID-19; COVID-19 vaccine; IBD; vaccine hesitancyvaccine hesitancybusinessCOVID-19 vaccineInflammatory Bowel Diseases
researchProduct